This Week in Pediatrics — Sep 14, 2026

Welcome to This Week in Pediatrics. This week we're covering 10 notable papers spanning firearm injury and the social determinants of critical illness, bedside recognition of the deteriorating child, cardiac disease and the developing brain, and precision therapeutics in chronic childhood disease. Let's dive in.

We'll start with injury and environment, where three papers converge on the idea that a great deal of paediatric acute illness is decided outside the hospital. Pediatrics published a retrospective analysis by Pandya and colleagues using the Pediatric Health Information System, covering more than six thousand emergency visits for firearm injury in children under eighteen between 2016 and 2023 [1]. Monthly emergency visits roughly doubled over that period, from about forty-four a month to eighty-three. The steep rise clustered around change points in March and June of 2020, and after that early pandemic surge there was no statistically significant further linear increase — but volumes never came back down. In other words, the pandemic did not cause a spike so much as reset the baseline. Importantly, the proportion of children admitted and the proportion who died in hospital stayed flat, at roughly half admitted and somewhere between about six and eight percent mortality, which tells you the extra cases reflect more injuries, not more severe ones. The burden fell overwhelmingly on adolescents, on boys, on Black children, and on children with public insurance. A second paper in Pediatrics, from Diaz and colleagues, asks where those injuries happen and why [2]. This was an ecological study across forty-six states and the District of Columbia, linking twenty-nine zip-code-level variables to emergency medical services responses and to the Gun Violence Archive between 2018 and 2022. Across nearly twenty-nine thousand zip codes, only about one in twenty recorded any paediatric firearm incident at all — the harm is extraordinarily concentrated. The strongest predictors were structural racism measured across social cohesion, built environment, employment, housing and criminal justice, along with urbanicity, household income, unemployment, educational opportunity, and state laws governing background checks and firearm access. These are ecological associations, not individual-level causation, but they identify modifiable targets. The same logic runs through a retrospective cohort study in Archives of Disease in Childhood from Vadibeler and colleagues, covering nearly forty-two thousand paediatric intensive care admissions for respiratory illness in England over a decade [3]. Children of Asian and Black ethnicity and children from the most deprived neighbourhoods were admitted substantially more often than White children and those from the least deprived areas — roughly a fifty to seventy percent higher admission rate. Children living in areas with the highest cigarette smoke exposure had about a thirty percent higher admission rate than those in the lowest-exposure areas. And the disparities extended to death in intensive care, with children of Asian ethnicity and those from deprived areas dying more often. The practical message is that community-level tobacco control is a paediatric respiratory intervention.

The second theme is recognising and assessing the acutely unwell child at the bedside. Archives of Disease in Childhood carries a review from Jump Salcedo and Owens on the evolving landscape of paediatric sepsis [4]. They trace the shift from inflammation-based definitions to the Phoenix Sepsis Criteria, which centre on life-threatening organ dysfunction, and the reshaping of invasive bacterial infection by conjugate vaccine programmes. Their central uncomfortable observation is that many paediatric sepsis deaths occur within the first twenty-four hours of referral to intensive care — meaning outcome is often determined before the child ever reaches the unit. Screening tools perform imperfectly in unselected febrile children, biomarkers remain adjuncts, and clinicians still lean on gestalt and parental concern. The authors argue the future lies in risk stratification rather than universal screening, with machine learning and phenotype-informed trial design — but they are explicit that both need prospective validation before routine use. Alongside that, the European Journal of Pediatrics publishes a narrative review from Zoica and colleagues on point-of-care ultrasound for the general paediatrician [5]. They define a pragmatic core scope: lung imaging, focused cardiac assessment, and ultrasound-guided vascular access. Lung ultrasound shows high diagnostic accuracy for consolidation and pleural effusion and may reduce reliance on chest radiography; focused cardiac views inform fluid responsiveness and can flag cardiogenic shock early; and ultrasound guidance improves cannulation success in children with difficult access. The caveat is governance — adoption across Europe is uneven, training and credentialing are inconsistent, and the authors propose a tiered competency framework with routine image archiving rather than ad hoc scanning.

Third, the heart and the brain. Pediatrics reports a forty-year single-centre Italian cohort from Bonanni and colleagues, following 533 children with Kawasaki disease diagnosed between 1982 and 2025 [6]. Acute coronary involvement occurred in about one in five children, but the great majority of that was dilation; only twenty-seven children developed aneurysms. The key finding is that persistent long-term coronary abnormality was seen exclusively in patients with medium or giant aneurysms — dilation resolved. Intravenous immunoglobulin use rose from just over half of patients in the 1980s to essentially universal after 2020, and the worst decade for both immunoglobulin resistance and coronary lesions was 2011 to 2020, with a decline thereafter. Four independent predictors of aneurysm stand out: age under six months, which raised the odds roughly eightfold; immunoglobulin resistance, which raised them about tenfold; treatment given after day ten, which raised them about fivefold; and pericardial effusion, roughly tripling the odds. Notably, no persistent coronary sequelae occurred in high-risk patients treated with interleukin-1 inhibitors, though those numbers are small. Two of those predictors — treatment timing and escalation for resistance — are things we control. Complementing that, Pediatric Research publishes a narrative review from Dogan and colleagues synthesising eleven MRI-based cohort studies of more than fifteen hundred infants with congenital heart disease [7]. Preoperative brain injury is detected in somewhere between about one in eight and more than half of neonates depending on cohort, most often white matter injury, arterial ischaemic stroke or haemorrhage — and crucially, much of it precedes surgery. Postoperative imaging is dominated by white matter injury and focal thromboembolic infarction. Risk factors span placental dysfunction and preeclampsia, prematurity and low birth weight, and procedural factors including surgical timing, bypass technique and extracorporeal support. The clinical implication is that neuroprotection in congenital heart disease has to start antenatally, and that these children need structured long-term neurodevelopmental surveillance, not just cardiac follow-up.

Finally, three papers on precision management of chronic disease. In the Journal of Pediatric Gastroenterology and Nutrition, Cerchione and colleagues report a dual-centre retrospective study of 136 children with cystic fibrosis on highly effective modulators for at least twelve months [8]. Faecal elastase rose modestly across the group, and just under half of children with exocrine insufficiency showed some increase — but a clinically relevant rise of at least a hundred micrograms per gram occurred in only five children at twelve months and three more at twenty-four, and exactly one child stopped enzyme replacement. Body mass index z-score, lung function and sweat chloride all improved significantly. Among pancreatic-sufficient children, none with prior recurrent acute pancreatitis had a recurrence. So counsel families realistically: established exocrine insufficiency rarely reverses, and enzyme replacement should not be stopped speculatively. In the European Journal of Pediatrics, Machinena-Spera and colleagues studied fifty-one young children with IgE-mediated hen's egg allergy undergoing a supervised baked egg challenge [9]. Just over half of the children tolerated baked egg. Ovomucoid-specific IgE was the best single predictor, with modest discrimination, and it held up in adjusted analysis, while skin prick testing and basophil activation testing added nothing meaningful. Reassuringly, epinephrine was needed in only two of the twenty-two non-tolerant children, and prior anaphylaxis did not significantly reduce the chance of tolerance. This is exploratory, single-centre work needing multicentre validation, but it supports supervised challenge rather than blanket avoidance. And the European Journal of Pediatrics also publishes a review from Gopukumar and colleagues on Rett syndrome [10], reframing it as a multisystem disorder — breathing dysrhythmia, QTc prolongation, enteric dysmotility, low bone density — rather than a purely neurological one. They are appropriately sober about the therapeutic pipeline: rodent rescue after MECP2 reactivation justifies disease-modifying approaches but does not establish reversibility in patients, gene therapy programmes carry a real safety signal including a fatal high-dose hyperinflammatory event, and the absence of any validated biomarker remains the principal obstacle.

If you only have time for one paper this week, make it the forty-year Kawasaki disease cohort in Pediatrics [6]. It gives you four concrete, largely modifiable predictors of the one outcome that actually matters long term, and it reframes coronary dilation as far less ominous than aneurysm.

Here are the key takeaways from this week in Pediatrics. Paediatric firearm injury has settled at a new, higher baseline since 2020, driven by incidence rather than severity, and the risk is concentrated in identifiable communities shaped by structural disadvantage and by firearm legislation. Neighbourhood deprivation, ethnicity and area-level smoke exposure predict both admission to paediatric intensive care for respiratory illness and death there, which makes tobacco control a paediatric intervention. In Kawasaki disease, only medium and giant aneurysms produce persistent coronary sequelae, and delayed immunoglobulin plus unrecognised resistance are the drivers you can change. In congenital heart disease, brain injury frequently begins before the operating room, so neurodevelopmental surveillance should be routine. And in cystic fibrosis, modulators improve nutrition, lung function and sweat chloride, but established exocrine pancreatic insufficiency rarely reverses.

That's your roundup for This Week in Pediatrics. The full transcript and references are available on the episode page in your AudioScholar library. This is an AI-curated summary — for clinical decisions, always consult primary sources and current guidelines. See you next week.

If this weekly briefing is useful, follow the show in your podcast app so new episodes arrive automatically. And a quick rating on Apple Podcasts or Spotify helps other physicians discover the show.

This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.